Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 241

1.

Favourable prognostic impact of RAS mutation status in multiple myeloma treated with High-Dose Melphalan and Autologous Stem Cell Support in the era of novel agents - a single centre perspective.

Gebauer N, Biersack H, Czerwinska AC, Schemme J, Hardel TT, Bernard V, Rades D, Lehnert H, Luley KB, Thorns C.

Leuk Lymphoma. 2015 May 7:1-9. [Epub ahead of print] No abstract available.

PMID:
25947035
2.

A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.

Rades D, Huttenlocher S, Veninga T, Bajrovic A, Bremer M, Rudat V, Schild SE.

Radiat Oncol. 2015 Apr 15;10(1):90. doi: 10.1186/s13014-015-0403-y.

3.

Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck.

Rades D, Huttenlocher S, Seibold ND, Gebhard MP, Thorns C, Hasselbacher K, Wollenberg B, Schild SE.

BMC Cancer. 2015 Mar 6;15:102. doi: 10.1186/s12885-015-1107-2.

4.

A new tool to predict survival after radiosurgery alone for newly diagnosed cerebral metastases.

Rades D, Huttenlocher S, Dziggel L, Blanck O, Hornung D, Mai KT, Ngo TT, Pham TV, Schild S.

Asian Pac J Cancer Prev. 2015;16(7):2967-70.

5.

A new instrument for estimating the survival of patients with metastatic epidural spinal cord compression from esophageal cancer.

Rades D, Huttenlocher S, Bajrovic A, Karstens JH, Bartscht T.

Radiol Oncol. 2015 Mar 3;49(1):86-90. doi: 10.2478/raon-2014-0043. eCollection 2015 Mar.

6.

Pulmonary vein isolation by radiosurgery: implications for non-invasive treatment of atrial fibrillation.

Bode F, Blanck O, Gebhard M, Hunold P, Grossherr M, Brandt S, Vonthein R, Thiele H, Dunst J, Rades D.

Europace. 2015 Mar 3. pii: euu406. [Epub ahead of print]

PMID:
25736725
7.

Predicting the survival probability of gastric cancer patients developing metastatic epidural spinal cord compression (MESCC).

Rades D, Huttenlocher S, Bartscht T, Schild SE.

Gastric Cancer. 2015 Jan 15. [Epub ahead of print]

PMID:
25588752
8.

Predicting survival of patients with metastatic epidural spinal cord compression from cancer of the head-and-neck.

Rades D, Schild SE, Karstens JH, Hakim SG.

Anticancer Res. 2015 Jan;35(1):385-8.

PMID:
25550576
9.

Radiosurgery with 20 Gy provides better local contol of 1-3 brain metastases from breast cancer than with lower doses.

Rades D, Huttenlocher S, Rudat V, Hornung D, Blanck O, Phuong PC, Khoa MT, Schild SE, Fischer D.

Anticancer Res. 2015 Jan;35(1):333-6.

PMID:
25550568
10.

A new tool predicting survival after radiosurgery alone for one or two cerebral metastases from lung cancer.

Rades D, Huttenlocher S, Dziggel L, Khoa MT, Van Thai P, Hornung D, Schild SE.

Lung. 2015 Apr;193(2):299-302. doi: 10.1007/s00408-014-9676-4. Epub 2014 Dec 21.

PMID:
25528743
11.

Genomic landscape of pancreatic neuroendocrine tumors.

Gebauer N, Schmidt-Werthern C, Bernard V, Feller AC, Keck T, Begum N, Rades D, Lehnert H, Brabant G, Thorns C.

World J Gastroenterol. 2014 Dec 14;20(46):17498-506. doi: 10.3748/wjg.v20.i46.17498.

12.

Comparison of two dose levels of stereotactic radiosurgery for 1-3 brain metastases from non-small cell lung cancer.

Rades D, Huttenlocher S, Dahlke M, Hornung D, Blanck O, Van Thai P, Trang NT, Khoa MT, Schild SE.

Anticancer Res. 2014 Dec;34(12):7309-13.

PMID:
25503165
13.

Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer.

Rades D, Huttenlocher S, Hornung D, Blanck O, Schild SE.

BMC Cancer. 2014 Dec 11;14:931. doi: 10.1186/1471-2407-14-931.

14.

Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?

Rades D, Huttenlocher S, Hornung D, Blanck O, Schild SE, Fischer D.

Radiat Oncol. 2014 Dec 4;9:267. doi: 10.1186/s13014-014-0267-6.

15.

Radiotherapy beyond cancer: target localization in real-time MRI and treatment planning for cardiac radiosurgery.

Ipsen S, Blanck O, Oborn B, Bode F, Liney G, Hunold P, Rades D, Schweikard A, Keall PJ.

Med Phys. 2014 Dec;41(12):120702. doi: 10.1118/1.4901414.

16.

Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large B-cell lymphomas of the thyroid--a study of 21 cases.

Knief J, Gebauer N, Bernard V, Schemme J, Reddemann K, Gebauer J, Rades D, Brabant G, Lehnert H, Feller AC, Thorns C.

J Clin Endocrinol Metab. 2015 Feb;100(2):754-62. doi: 10.1210/jc.2014-3250. Epub 2014 Nov 25.

PMID:
25423572
17.

Predicting overall survival in patients with brain metastases from esophageal cancer.

Rades D, Dziggel L, Bartscht T, Gliemroth J.

Anticancer Res. 2014 Nov;34(11):6763-5.

PMID:
25368288
18.

Motor function and survival following radiotherapy alone for metastatic epidural spinal cord compression in melanoma patients.

Huttenlocher S, Sehmisch L, Rudat V, Rades D.

J Dermatol. 2014 Dec;41(12):1082-6. doi: 10.1111/1346-8138.12659. Epub 2014 Oct 20.

PMID:
25327333
19.

Identifying melanoma patients with 1-3 brain metastases who may benefit from whole-brain irradiation in addition to radiosurgery.

Huttenlocher S, Sehmisch L, Schild SE, Blank O, Hornung D, Rades D.

Anticancer Res. 2014 Oct;34(10):5589-92.

PMID:
25275060
20.

Activating mutations affecting the NF-kappa B pathway and EZH2-mediated epigenetic regulation are rare events in primary mediastinal large B-cell lymphoma.

Gebauer N, Hardel TT, Gebauer J, Bernard V, Merz H, Feller AC, Rades D, Biersack H, Lehnert H, Thorns C.

Anticancer Res. 2014 Oct;34(10):5503-7.

PMID:
25275047
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk